CoreWeave vs Nebius: Both Companies Reported Strong Earnings, But Here’s the Stock You Should Buy
Key Points:
- Nebius (NBIS) reported an exceptional quarter with revenue soaring 454% year-over-year to $582.3 million and adjusted EBITDA swinging from a $21 million loss to a $236.2 million profit; its stock surged 34.14% following the report.
- CoreWeave (CRWV) also posted strong revenue growth, more than doubling to $2.58 billion, but its net loss widened to $626 million due to heavy interest expenses on $35.6 billion in debt, causing its stock to rise 19.28%.
- Nebius maintains a healthier balance sheet with $8 billion in cash against $8.5 billion in debt and lower interest expenses, while CoreWeave faces a significant net debt burden exceeding $30 billion, impacting profitability.
- Despite CoreWeave trading at a cheaper forward price-to-sales ratio (3.90x vs. Nebius’s 14.64x), Nebius’s faster growth, profitability, and cash flow generation justify its higher valuation and make it the preferred investment.
- Analyst sentiment remains positive for both firms, with CoreWeave holding a Moderate Buy consensus and price targets around $136, while Nebius has a stronger Moderate Buy consensus and higher price targets up to $410, reflecting confidence in its growth trajectory.